NCT05359211 2026-03-20NKTR-255 in Combination With CAR-T Cell Therapy for the Treatment of Relapsed or Refractory Large B-cell LymphomaFred Hutchinson Cancer CenterPhase 1 Active not recruiting27 enrolled
NCT03233854 2025-11-18CD19/CD22 Chimeric Antigen Receptor (CAR) T Cells With or Without NKTR-255 in Adults With Recurrent or Refractory B Cell MalignanciesStanford UniversityPhase 1 Active not recruiting56 enrolled